Table of Contents

1 Market Overview
1.1 Rabies Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Vero cell rabies vaccine
1.2.2 BHK
1.2.3 Chick embryo cell rabies vaccine
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Pre-exposure Prophylaxis
1.3.2 Post-exposure Prophylaxis
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK (Novartis)
2.1.1 Business Overview
2.1.2 Rabies Vaccine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi-Pasteur
2.2.1 Business Overview
2.2.2 Rabies Vaccine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Chengda
2.3.1 Business Overview
2.3.2 Rabies Vaccine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Chengda Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Yisheng
2.4.1 Business Overview
2.4.2 Rabies Vaccine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Prcmise
2.5.1 Business Overview
2.5.2 Rabies Vaccine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 VACN
2.6.1 Business Overview
2.6.2 Rabies Vaccine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 VACN Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Changsheng
2.7.1 Business Overview
2.7.2 Rabies Vaccine Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 BCHT
2.8.1 Business Overview
2.8.2 Rabies Vaccine Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 BCHT Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hissen
2.9.1 Business Overview
2.9.2 Rabies Vaccine Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Hissen Rabies Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Rabies Vaccine Market Competition, by Manufacturer
3.1 Global Rabies Vaccine Sales and Market Share by Manufacturer
3.2 Global Rabies Vaccine Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Rabies Vaccine Manufacturer Market Share
3.3.2 Top 6 Rabies Vaccine Manufacturer Market Share
3.4 Market Competition Trend
4 Global Rabies Vaccine Market Analysis by Regions
4.1 Global Rabies Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Rabies Vaccine Sales by Regions (2012-2017)
4.1.2 Global Rabies Vaccine Revenue by Regions (2012-2017)
4.2 North America Rabies Vaccine Sales and Growth (2012-2017)
4.3 Europe Rabies Vaccine Sales and Growth (2012-2017)
4.4 Asia-Pacific Rabies Vaccine Sales and Growth (2012-2017)
4.5 South America Rabies Vaccine Sales and Growth (2012-2017)
4.6 Middle East and Africa Rabies Vaccine Sales and Growth (2012-2017)
5 North America Rabies Vaccine by Countries
5.1 North America Rabies Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Rabies Vaccine Sales by Countries (2012-2017)
5.1.2 North America Rabies Vaccine Revenue by Countries (2012-2017)
5.2 USA Rabies Vaccine Sales and Growth (2012-2017)
5.3 Canada Rabies Vaccine Sales and Growth (2012-2017)
5.4 Mexico Rabies Vaccine Sales and Growth (2012-2017)
6 Europe Rabies Vaccine by Countries
6.1 Europe Rabies Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Rabies Vaccine Sales by Countries (2012-2017)
6.1.2 Europe Rabies Vaccine Revenue by Countries (2012-2017)
6.2 Germany Rabies Vaccine Sales and Growth (2012-2017)
6.3 UK Rabies Vaccine Sales and Growth (2012-2017)
6.4 France Rabies Vaccine Sales and Growth (2012-2017)
6.5 Russia Rabies Vaccine Sales and Growth (2012-2017)
6.6 Italy Rabies Vaccine Sales and Growth (2012-2017)
7 Asia-Pacific Rabies Vaccine by Countries
7.1 Asia-Pacific Rabies Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Rabies Vaccine Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Rabies Vaccine Revenue by Countries (2012-2017)
7.2 China Rabies Vaccine Sales and Growth (2012-2017)
7.3 Japan Rabies Vaccine Sales and Growth (2012-2017)
7.4 Korea Rabies Vaccine Sales and Growth (2012-2017)
7.5 India Rabies Vaccine Sales and Growth (2012-2017)
7.6 Southeast Asia Rabies Vaccine Sales and Growth (2012-2017)
8 South America Rabies Vaccine by Countries
8.1 South America Rabies Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Rabies Vaccine Sales by Countries (2012-2017)
8.1.2 South America Rabies Vaccine Revenue by Countries (2012-2017)
8.2 Brazil Rabies Vaccine Sales and Growth (2012-2017)
8.3 Argentina Rabies Vaccine Sales and Growth (2012-2017)
8.4 Columbia Rabies Vaccine Sales and Growth (2012-2017)
9 Middle East and Africa Rabies Vaccine by Countries
9.1 Middle East and Africa Rabies Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Rabies Vaccine Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Rabies Vaccine Revenue by Countries (2012-2017)
9.2 Saudi Arabia Rabies Vaccine Sales and Growth (2012-2017)
9.3 UAE Rabies Vaccine Sales and Growth (2012-2017)
9.4 Egypt Rabies Vaccine Sales and Growth (2012-2017)
9.5 Nigeria Rabies Vaccine Sales and Growth (2012-2017)
9.6 South Africa Rabies Vaccine Sales and Growth (2012-2017)
10 Global Rabies Vaccine Market Segment by Type
10.1 Global Rabies Vaccine Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Rabies Vaccine Sales and Market Share by Type (2012-2017)
10.1.2 Global Rabies Vaccine Revenue and Market Share by Type (2012-2017)
10.2 Vero cell rabies vaccine Sales Growth and Price
10.2.1 Global Vero cell rabies vaccine Sales Growth (2012-2017)
10.2.2 Global Vero cell rabies vaccine Price (2012-2017)
10.3 BHK Sales Growth and Price
10.3.1 Global BHK Sales Growth (2012-2017)
10.3.2 Global BHK Price (2012-2017)
10.4 Chick embryo cell rabies vaccine Sales Growth and Price
10.4.1 Global Chick embryo cell rabies vaccine Sales Growth (2012-2017)
10.4.2 Global Chick embryo cell rabies vaccine Price (2012-2017)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2012-2017)
10.5.2 Global Other Price (2012-2017)
11 Global Rabies Vaccine Market Segment by Application
11.1 Global Rabies Vaccine Sales Market Share by Application (2012-2017)
11.2 Pre-exposure Prophylaxis Sales Growth (2012-2017)
11.3 Post-exposure Prophylaxis Sales Growth (2012-2017)
12 Rabies Vaccine Market Forecast (2017-2022)
12.1 Global Rabies Vaccine Sales, Revenue and Growth Rate (2017-2022)
12.2 Rabies Vaccine Market Forecast by Regions (2017-2022)
12.2.1 North America Rabies Vaccine Market Forecast (2017-2022)
12.2.2 Europe Rabies Vaccine Market Forecast (2017-2022)
12.2.3 Asia-Pacific Rabies Vaccine Market Forecast (2017-2022)
12.2.4 South America Rabies Vaccine Market Forecast (2017-2022)
12.2.5 Middle East and Africa Rabies Vaccine Market Forecast (2017-2022)
12.3 Rabies Vaccine Market Forecast by Type (2017-2022)
12.4 Rabies Vaccine Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source